作为内分泌血管调节剂的红细胞氧化:在充血性心力衰竭中发挥潜在作用
Borunendra Datta1, Timothy Tufnell-Barrett, Robert A Bleasdale
1Department of Cardiology, Wales Heart Research Institute, University of Wales College of Medicine, Heath Park, Cardiff, UK.
Circulation
|March 17, 2004
概括
红细胞释放氧化 (NO) 在缺氧期间放松血管. 这种NO运输机制在充血性心力衰竭 (CHF) 患者中发生了变化,影响了血流调节.
科学领域:
- 生理学 生理学 生理学
- 心血管科学 心血管科学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 氧化 (NO) 在调节血管度方面发挥作用.
- 血管活性代谢物在氧化过程中在NO和血红蛋白之间形成.
- 这些代谢物的功能在低氧条件下需要进一步研究.
研究的目的:
- 为了研究NO-血红蛋白代谢物在缺氧血管扩张中的作用.
- 在健康个体和患有充血性心力衰竭 (CHF) 的患者中检查这些机制.
主要方法:
- 在不同氧气压力下使用预先收缩的大动脉环和红细胞 (RBC) 的体外研究.
- 在体内测量健康受试者和CHF患者中NO代谢物的跨肺梯度.
主要成果:
- 红细胞在缺氧期间诱导了血管松,依赖于循环瓜尼利单酸盐,与S-尼特罗斯红血球 (SNO-Hb) 水平相关.
- 红细胞的缺氧血管扩张在较低的氧气张力时更为明显,这表明一种全性机制.
- 与对照组相比,CHF患者表现出SNO-Hb和铁基血红蛋白 (HbFeNO) 的转肺梯度变化,与心脏指数相反相关.
结论:
- 结合红细胞的NO通过异质机制调解缺氧血管扩张.
- 在CHF患者中,改变的NO代谢物渐变与心脏功能受损有关.
- 血红蛋白促进NO的运输到缺氧组织,这个过程在CHF中可能受到失调.
相关概念视频
Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Hormonal Regulation of Blood Pressure
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...


